Corporate Announcement
Security Code : 530019    Company : JUBLPHARMA    
 
Announces Q3 Results (Standalone & Consolidated), Limited Review Report (Standalone & Consolidated), Results Press Release & Presentation for the Quarter ended December 31, 2015 
  Exchange Disseminated Time     
Jubilant Life Sciences Ltd has announced the following results for the quarter ended December 31, 2015:

The Unaudited Standalone results for the Quarter ended December 31, 2015

The Company has posted a net profit of Rs. 282.30 million for the quarter ended December 31, 2015 where as the same was net loss at Rs. (84.80) million for the quarter ended December 31, 2014. Total Income is Rs. 6531.20 million for the quarter ended December 31, 2015 where as the same was at Rs. 7411.90 million for the quarter ended December 31, 2014.

The Consolidated Results are as follows:

The Unaudited Consolidated results for the Quarter ended December 31, 2015

The Group has posted a net profit after taxes, minority interest and share of profit of associates of Rs. 1169.30 million for the quarter ended December 31, 2015 where as the same was net loss at Rs. (111.60) million for the quarter ended December 31, 2014. Total Income is Rs. 13823.00 million for the quarter ended December 31, 2015 where as the same was at Rs. 14515.30 million for the quarter ended December 31, 2014.

- Previous periods figures have been reclassified to conform to the current period's classification. Further, the figures for the current period are not comparable to the previous periods due to transfer of certain businesses to Jubilant Generics Limited, a step-down wholly owned subsidiary with effect from July 01, 2014.
 

Disclaimer

Back To Announcements